Daiwa Securities Group’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4
Closed 1342
2022
Q3
$0 Hold
4
﹤0.01% 1361
2022
Q2
$0 Hold
4
﹤0.01% 1390
2022
Q1
$0 Hold
4
﹤0.01% 1392
2021
Q4
$0 Hold
4
﹤0.01% 1411
2021
Q3
$0 Hold
4
﹤0.01% 1324
2021
Q2
$0 Hold
4
﹤0.01% 1272
2021
Q1
$1K Hold
4
﹤0.01% 1201
2020
Q4
$1K Buy
+4
New +$718 ﹤0.01% 1181
2018
Q3
Sell
-1
Closed -$2K 1178
2018
Q2
$2K Hold
1
﹤0.01% 1137
2018
Q1
$2K Buy
+1
New +$2.29K ﹤0.01% 1126

Other funds holding IMUX

Daiwa Securities Group's IMUX Position: Q4 2022 in Review

Daiwa Securities Group sold out of Immunic (IMUX) in Q4 2022, closing a stake of 4 shares.

Daiwa Securities Group first reported a position in IMUX in Q1 2018 and held it in 10 quarters. The position peaked at $2K in Q2 2018. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

  • Daiwa Securities Group reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 4 Immunic shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Immunic in Q1 2018 and held it in 10 quarters.
  • Daiwa Securities Group's Immunic position peaked at $2K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.